Exparel

Viatris has agreed to acquire Pacira BioSciences, the maker of the non-opioid pain medication Exparel. The deal is billed as a step forward in Viatris's strategy to expand its innovative medicines portfolio and position the company as a leader in non-opioid pain therapies. Financial terms and expected closing timelines were not detailed in the announcement, which was released through the company's newsroom.